ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,195Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 973

$543K Total Retail Price of All Prescriptions

Rank: 115 out of 973

684 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 684 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 684 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,598 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
HYDROCODONE-ACETAMINOPHEN 440 205 S3 1 4
AMLODIPINE BESYLATE 390 292 2 7
LISINOPRIL 375 208 3 3
OMEPRAZOLE 369 192 4 5
LEVOTHYROXINE SODIUM 355 316 5 2
FUROSEMIDE 348 245 6 6
HYDROCHLOROTHIAZIDE 290 188 7 11
CITALOPRAM HBR 270 185 8 14
BOOSTRIX 250 225 9 243
METFORMIN HCL 250 135 9 8
WARFARIN SODIUM 237 201 11 10
GABAPENTIN 218 100 12 12
SIMVASTATIN 173 110 13 1
METOPROLOL SUCCINATE 162 114 14 17
ZOLPIDEM TARTRATE 157 69 15 20
METOPROLOL TARTRATE 149 122 16 13
SERTRALINE HCL 137 88 17 21
OXYCODONE HCL 137 33 S2 17 79
CYCLOBENZAPRINE HCL 136 20 R 19 42
LOSARTAN POTASSIUM 135 125 20 19
POTASSIUM CHLORIDE 135 92 20 9
TRAMADOL HCL 134 62 22 18
CARVEDILOL 129 76 23 27
NEXIUM 121 63 24 30
TAMSULOSIN HCL 115 76 25 28
FENTANYL 98 62 S2 26 53
SPIRIVA 95 52 27 73
ALLOPURINOL 91 72 28 29
TRAZODONE HCL 89 25 29 48
PREDNISONE 85 51 30 33
PANTOPRAZOLE SODIUM 79 38 31 37
ATORVASTATIN CALCIUM 78 49 32 15
PROAIR HFA 77 14 33 54
CLONIDINE HCL 76 48 34 67
VENLAFAXINE HCL ER 74 18 35 95
POLYETHYLENE GLYCOL 3350 72 37 36 36
MIRTAZAPINE 69 57 37 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 52 38 25
ISOSORBIDE MONONITRATE ER 66 50 39 85
ATENOLOL 66 46 39 16
MELOXICAM 65 26 41 23
DIVALPROEX SODIUM 64 0 42 86
ADVAIR DISKUS 64 50 42 60
DONEPEZIL HCL 61 61 44 26
AZITHROMYCIN 59 32 45 47
FLUTICASONE PROPIONATE 57 22 46 35
PRAVASTATIN SODIUM 57 33 46 22
CYMBALTA 57 0 46 40
GLIPIZIDE 56 34 49 69
LANTUS 55 26 50 39
GLYBURIDE 54 44 R 51 59
RANITIDINE HCL 53 32 52 45
ROPINIROLE HCL 52 30 53 72
GEMFIBROZIL 50 12 54 83
VYTORIN 50 12 54 154
GLIMEPIRIDE 50 48 54 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.